RA Capital Management, L.P. 13D and 13G filings for Solid Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-21 4:15 pm Purchase |
2025-02-19 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 7,989,820 9.900% |
3,631,342 (+83.32%) |
Filing |
| 2024-06-12 6:26 pm Purchase |
2024-06-11 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 4,358,478 11.300% |
9,650 (+0.22%) |
Filing |
| 2024-01-11 5:24 pm Purchase |
2024-01-11 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 4,348,828 11.700% |
917,210 (+26.73%) |
Filing |
| 2022-12-05 5:12 pm Purchase |
2022-12-02 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 3,431,618 17.570% |
2,601,760 (+313.52%) |
Filing |
| 2022-10-04 5:14 pm Unchanged |
2022-09-29 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 829,858 11.010% |
0 (Unchanged) |
Filing |
| 2022-09-06 4:50 pm Purchase |
2022-09-02 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 829,858 11.010% |
5,333 (+0.65%) |
Filing |
| 2021-03-23 4:32 pm Purchase |
2009-02-28 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 824,525 11.600% |
159,420 (+23.97%) |
Filing |
| 2020-12-16 5:24 pm Purchase |
2009-02-28 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 665,105 11.800% |
360,360 (+118.25%) |
Filing |